Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open‐label, parallel‐group, noninferiority phase III trial

Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open‐label, parallel‐group, noninferiority phase III trial

Abstract Background This study was to explore the clinical efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection (recombinant human erythropoietin injection, rHuEPO) for the treatment of anemia associated with chronic kidney failure in Chinese patients undergoing hemodia...

Full description

Bibliographic Details
Main Authors: Bicheng Liu, Nan Chen, Jinghong Zhao, Aiping Yin, Xiongfei Wu, Changying Xing, Gengru Jiang, Junzhou Fu, Mei Wang, Rong Wang, Jianying Niu, Ping Fu, Zhaohui Ni, Fanfan Hou, Jiuyang Zhao, Jing Chen, Yuqing Chen, Wei Shi, Jianghua Chen, Wenge Li, Gang Xu, Ling Zhong, Wenhu Liu, Guohua Ding, Yuichiro Kondo, Changhe Yue, Changlin Mei
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Chronic Diseases and Translational Medicine
Subjects:
anemia
conversion ratio
darbepoetin alfa
epoetin alfa
hemodialysis
Online Access:https://doi.org/10.1002/cdt3.23

Internet

https://doi.org/10.1002/cdt3.23

Similar Items